Orthofix International | OFIX - Operating Profit


Orthofix International reported $6.12M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Hologic USD 237M 16M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
STAAR Surgical USD -10.93M 29.42M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Veracyte USD 24.63M 1.52M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025